Reactivation tuberculosis in a patient with anti-TNF-alpha treatment.
Núñez Martínez
O
O
Ripoll Noiseux
C
C
Carneros Martín
J A
JA
González Lara
V
V
Gregorio Marañón
H G
HG
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D014376:Tuberculosis / Q000503:physiopathology*; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab